Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT00064129 · COMPLETED

Trial details

NCT number: NCT00064129
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Prostate Carcinoma Stage IV Prostate Cancer AJCC v7

Start date: 2003-05-13
Primary completion: 2011-01-10
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.